Acadia Pharmaceuticals buy UBS Group AG
Start price
17.10.23
/
50%
€21.80
Target price
17.10.24
€31.28
Performance (%)
-36.33%
End price
18.10.24
€13.88
Summary
This prediction ended on 18.10.24 with a price of €13.88. The BUY prediction by UBS_Group_AG for Acadia Pharmaceuticals performed very badly with a performance of -36.33%. UBS_Group_AG has a follow-up prediction for Acadia Pharmaceuticals where he still thinks Acadia Pharmaceuticals is a Buy. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Acadia Pharmaceuticals | -12.151% | -12.151% | 5.753% |
| iShares Core DAX® | 0.754% | -1.027% | 14.485% |
| iShares Nasdaq 100 | -2.859% | -4.266% | 2.185% |
| iShares Nikkei 225® | 4.946% | 5.736% | 25.355% |
| iShares S&P 500 | -1.254% | -2.357% | 1.146% |
Comments by UBS_Group_AG for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $33.00 price target on the stock.
Ratings data for ACAD provided by MarketBeat
In the thread Trading Acadia Pharmaceuticals
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten
Current prediction by UBS_Group_AG for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€21.15
08.08.25
08.08.25
€30.87
08.08.26
08.08.26
-7.87%
09.02.26
09.02.26
Stopped prediction by UBS_Group_AG for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€23.07
06.01.26
06.01.26
€34.12
06.01.27
06.01.27
-15.54%
09.02.26
09.02.26
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€23.27
04.12.25
04.12.25
-
04.12.26
04.12.26
-16.27%
09.02.26
09.02.26
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€20.96
09.09.25
09.09.25
€33.13
09.09.26
09.09.26
-7.04%
09.02.26
09.02.26
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€14.56
08.08.24
08.08.24
€21.10
08.08.25
08.08.25
43.94%
09.08.25
09.08.25